Browse by author
Lookup NU author(s): Dr Juliane Mueller, Professor Hanns Lochmuller
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The neuromuscular junction (NMJ) is a complex structure that efficiently communicates the electrical impulse from the motor neuron to the skeletal muscle to induce muscle contraction. Genetic and autoimmune disorders known to compromise neuromuscular transmission are providing further insights into the complexities of NMJ function. Congenital myasthenic syndromes (CMSs) are a genetically and phenotypically heterogeneous group of rare hereditary disorders affecting neuromuscular transmission. The understanding of the molecular basis of the different types of CMSs has evolved rapidly in recent years. Mutations were first identified in the subunits of the nicotinic acetylcholine receptor (AChR), but now mutations in ten different genes - encoding post-, pre- or synaptic proteins - are known to cause CMSs. Pathogenic mechanisms leading to an impaired neuromuscular transmission modify AChRs or endplate structure or lead to decreased acetylcholine synthesis and release. However, the genetic background of many CMS forms is still unresolved. A precise molecular classification of CMS type is of paramount importance for the diagnosis, counselling and therapy of a patient, as different drugs may be beneficial or deleterious depending on the molecular background of the particular CMS. © 2007 Cambridge University Press.
Author(s): Muller JS, Mihaylova V, Abicht A, Lochmuller H
Publication type: Review
Publication status: Published
Journal: Expert Reviews in Molecular Medicine
Year: 2007
Volume: 9
Issue: 22
Pages: 1-20
ISSN (print): 1462-3994
ISSN (electronic):
URL: http://dx.doi.org/10.1017/S1462399407000427
DOI: 10.1017/S1462399407000427
PubMed id: 17686188
